Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quick Finger-Prick test may keep feverish kids out of ER

NCT ID NCT06910631

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a rapid finger-prick test for C-reactive protein (CRP) can help doctors decide if a child with fever needs emergency care or can be safely managed at home. About 420 children aged 2-9 with fever will be enrolled. The goal is to reduce unnecessary ER visits and streamline care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 420 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 months to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient must be a member or beneficiary of a health insurance plan * Children consulting primary health institutes with fever (temperature ≥ 38°C) requiring CRP testing: * Fever \> 12h in infants aged 3 to 6 months * Fever ≥ 5 days in children over 6 months of age * Fever \>12h regardless of age, and at the time of consultation, the doctor is concerned about the child's general condition, the tolerance of the fever, or doubts about a bacterial focus (e.g. suspicion of pneumopathy, appendicitis, etc.). * No severity criteria necessitating immediate hospitalization * No bacterial infection whose diagnosis is exclusively clinical or identified by other means (e.g. purulent AOM, bacterial angina identified by RDT, etc.). * Child whose parents and child have been informed about the study, and at least one parent has given consent for their child's participation in the study. * Enrolment of the child according to their capacity of discernment (for children aged 12 and over, enrolment is essential). * Child affiliated to or benefiting from a health insurance scheme Exclusion Criteria: * The subject is participating in a category 1 interventional study, or a study with drug or medical device * Premature infants under one year of age * Immunosuppression * Sunstroke * Chronic infection * Malignant pathology * Autoimmune pathology * Sickle cell disease * Child with a central catheter

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fever are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fever

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fever

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    37 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CABINET MEDICAL Perpignan

    RECRUITING

    Perpignan, France

  • CABINET MEDICAL Saint-Hippolyte-du-Fort

    RECRUITING

    Saint-Hippolyte-du-Fort, France

  • CABINET médical de l'Étang de l'Or

    RECRUITING

    Pérols, France

  • CDS Filieris Saint Martin de Valgalgues

    RECRUITING

    Saint-Martin-de-Valgalgues, France

  • CHU de Nîmes

    RECRUITING

    Nîmes, France

  • Cabinet Medical Baho

    RECRUITING

    Baho, France

  • Cds de Ma Region

    RECRUITING

    Le Vigan, France

  • Centre médical du Grau D'Agde

    RECRUITING

    Agde, France

  • MMG de Montpellier

    RECRUITING

    Montpellier, France

  • MMG de Narbonne

    RECRUITING

    Narbonne, France

  • MMG de Nîmes

    RECRUITING

    Nîmes, France

  • MSP Charles GIDE

    RECRUITING

    Nîmes, France

  • MSP Espace Santé Servian

    RECRUITING

    Béziers, France

  • MSP Le Prisme

    RECRUITING

    Remoulins, France

  • MSP Montpellier-Cévennes

    RECRUITING

    Montpellier, France

  • MSP OLEA

    RECRUITING

    Bezouce, France

  • MSP Pezenas Tourbes

    RECRUITING

    Tourbes, France

  • MSP Saint-Laurent d'Aigouze

    RECRUITING

    Saint-Laurent-d'Aigouze, France

  • MSP Sud Minervois

    RECRUITING

    Saint-Marcel-sur-Aude, France

  • MSP Terre de Béliers

    RECRUITING

    Bouillargues, France

  • MSP de Calvisson

    RECRUITING

    Calvisson, France

  • MSP de Clarensac

    RECRUITING

    Caveirac, France

  • MSP de Pont Saint Esprit

    RECRUITING

    Pont-Saint-Esprit, France

  • MSPU Avicenne

    RECRUITING

    Cabestany, France

  • MSPU Pauline Lautaud

    RECRUITING

    Prades-le-Lez, France

  • Maison de santé de St Quentin la Poterie

    RECRUITING

    Saint-Quentin-la-Poterie, France

  • Msp Au Fil de L'Hers

    RECRUITING

    Deyme, France

  • Msp Balmat Sante

    RECRUITING

    Béziers, France

  • Msp Du Thaurac

    RECRUITING

    Saint-Bauzille-de-Putois, France

  • Msp Gigean

    RECRUITING

    Gigean, France

  • Msp La Mosson

    RECRUITING

    Montpellier, France

  • Msp Le Cube

    RECRUITING

    Montgiscard, France

  • Msp Madeleine Bres

    RECRUITING

    Bouillargues, France

  • Msp Narbo-Ouest

    RECRUITING

    Narbonne, France

  • Msp Saint Jean-Du Gard

    RECRUITING

    Saint-Jean-du-Gard, France

  • Mspu La Source

    RECRUITING

    Vergèze, France

  • Mspu Pins Justaret

    RECRUITING

    Pins-Justaret, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.